Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
42,194,093
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
13,061,656
-
Shares change
-
+299,763
-
Total reported value, excl. options
-
$378,528,053
-
Value change
-
+$8,240,890
-
Number of buys
-
27
-
Number of sells
-
-16
-
Price
-
$28.98
Significant Holders of Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) as of Q2 2021
51 filings reported holding TARS - Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,061,656 shares
of 42,194,093 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (2,987,331 shares), RTW INVESTMENTS, LP (2,013,601 shares), Cormorant Asset Management, LP (1,514,269 shares), FRAZIER MANAGEMENT LLC (1,417,157 shares), PERCEPTIVE ADVISORS LLC (1,296,416 shares), TimesSquare Capital Management, LLC (686,705 shares), COWEN AND COMPANY, LLC (514,289 shares), Jefferies Group LLC (442,993 shares), BlackRock Inc. (438,329 shares), and VANGUARD GROUP INC (426,045 shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.